. Who-ebola-response and . Team, Ebola Virus Disease in West Africa ??? The First 9 Months of the Epidemic and Forward Projections, New England Journal of Medicine, vol.371, issue.16, pp.1481-1495, 2014.
DOI : 10.1056/NEJMoa1411100

X. Qiu, G. Wong, J. Audet, A. Bello, L. Fernando et al., Reversion of advanced Ebola virus disease in nonhuman primates with ZMapp, Nature, vol.27, pp.47-53, 2014.
DOI : 10.1086/514305

D. Sissoko, X. Anglaret, D. Malvy, E. Folkesson, M. Abdoul et al., Favipiravir in patients with Ebola virus disease: early results of the JIKI trial in Guinea Available: http://www. croiconference.org/sessions/favipiravir-patients-ebola-virus-disease-early-results-jiki-trial-guinea, Conference on Retroviruses and Opportunistic Infections Feb, vol.23, 2015.

T. Hampton, Largest-Ever Outbreak of Ebola Virus Disease Thrusts Experimental Therapies, Vaccines Into Spotlight, JAMA, vol.312, issue.10, pp.987-989, 2014.
DOI : 10.1001/jama.2014.11170

E. Cox, L. Borio, and R. Temple, Evaluating Ebola Therapies ??? The Case for RCTs, New England Journal of Medicine, vol.371, issue.25, pp.2350-2351, 2014.
DOI : 10.1056/NEJMp1414145

S. Joffe, Evaluating Novel Therapies During the Ebola Epidemic, JAMA, vol.312, issue.13, pp.1299-1300, 2014.
DOI : 10.1001/jama.2014.12867

S. Joffe, Ethical Testing of Experimental Ebola Treatments???Reply, JAMA, vol.313, issue.4, 2014.
DOI : 10.1001/jama.2014.17262

D. Shaw, Randomisation is essential in Ebola drug trials, The Lancet, vol.384, issue.9955, pp.140-673661735, 2014.
DOI : 10.1016/S0140-6736(14)61735-9

C. Adebamowo, O. Bah-sow, F. Binka, R. Bruzzone, A. Caplan et al., Randomised controlled trials for Ebola: practical and ethical issues, The Lancet, vol.384, issue.9952, pp.1423-1424, 2014.
DOI : 10.1016/S0140-6736(14)61734-7

M. Folayan, B. Haire, and K. Peterson, Ethical Testing of Experimental Ebola Treatments, JAMA, vol.313, issue.4, p.421, 2014.
DOI : 10.1001/jama.2014.17256

. Who-ebola-response, . Team, J. Agua-agum, A. Ariyarajah, B. Aylward et al., West African Ebola Epidemic after One Year ??? Slowing but Not Yet under Control, New England Journal of Medicine, vol.372, issue.6, pp.584-587, 2015.
DOI : 10.1056/NEJMc1414992

A. Lefebvre, C. Fiet, C. Belpois-duchamp, M. Tiv, K. Astruc et al., Case fatality rates of Ebola virus diseases: A meta-analysis of World Health Organization data, M??decine et Maladies Infectieuses, vol.44, issue.9, pp.412-416, 2014.
DOI : 10.1016/j.medmal.2014.08.005

T. Ksiazek, P. Rollin, A. Williams, D. Bressler, M. Martin et al., Clinical Virology of Ebola Hemorrhagic Fever (EHF): Virus, Virus Antigen, and IgG and IgM Antibody Findings among EHF Patients in Kikwit, Democratic Republic of the Congo, 1995, The Journal of Infectious Diseases, vol.179, issue.s1, pp.177-187, 1999.
DOI : 10.1086/514321

M. Weidmann, E. Muhlberger, and F. Hufert, Rapid detection protocol for filoviruses, Journal of Clinical Virology, vol.30, issue.1, pp.94-99, 2004.
DOI : 10.1016/j.jcv.2003.09.004

J. Schieffelin, J. Shaffer, A. Goba, M. Gbakie, S. Gire et al., Clinical Illness and Outcomes in Patients with Ebola in Sierra Leone, New England Journal of Medicine, vol.371, issue.22, pp.2092-2100, 2014.
DOI : 10.1056/NEJMoa1411680

J. Towner, P. Rollin, D. Bausch, A. Sanchez, S. Crary et al., Rapid Diagnosis of Ebola Hemorrhagic Fever by Reverse Transcription-PCR in an Outbreak Setting and Assessment of Patient Viral Load as a Predictor of Outcome, Journal of Virology, vol.78, issue.8, pp.4330-43414330, 2004.
DOI : 10.1128/JVI.78.8.4330-4341.2004

E. Bah, M. Lamah, T. Fletcher, S. Jacob, D. Brett-major et al., Clinical Presentation of Patients with Ebola Virus Disease in Conakry, Guinea, New England Journal of Medicine, vol.372, issue.1, pp.40-47, 2015.
DOI : 10.1056/NEJMoa1411249

S. Gire, A. Goba, K. Andersen, R. Sealfon, D. Park et al., Genomic surveillance elucidates Ebola virus origin and transmission during the 2014 outbreak, Science, vol.345, issue.6202, pp.1369-1372, 2014.
DOI : 10.1126/science.1259657

Y. Tong, W. Shi, L. Di, J. Qian, L. Liang et al., Genetic diversity and evolutionary dynamics of Ebola virus in Sierra Leone, Nature, vol.25, issue.7563, pp.93-96, 2015.
DOI : 10.1038/nature14490